De Marinis Grasso, Laura
 Distribuzione geografica
Continente #
EU - Europa 4.490
NA - Nord America 3.735
AS - Asia 781
SA - Sud America 14
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 9.041
Nazione #
US - Stati Uniti d'America 3.706
DE - Germania 2.007
SE - Svezia 793
CN - Cina 548
UA - Ucraina 546
IT - Italia 333
IE - Irlanda 217
FR - Francia 198
GB - Regno Unito 160
FI - Finlandia 118
IN - India 114
BE - Belgio 42
TR - Turchia 38
CA - Canada 27
JP - Giappone 26
RU - Federazione Russa 20
NL - Olanda 16
HK - Hong Kong 13
IR - Iran 10
SG - Singapore 10
VN - Vietnam 10
CH - Svizzera 9
CI - Costa d'Avorio 8
PL - Polonia 6
AU - Australia 4
BR - Brasile 4
CO - Colombia 4
ES - Italia 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
IL - Israele 3
PE - Perù 3
AL - Albania 2
CR - Costa Rica 2
EU - Europa 2
IQ - Iraq 2
LT - Lituania 2
MD - Moldavia 2
BD - Bangladesh 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
LI - Liechtenstein 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 9.041
Città #
Chandler 847
Jacksonville 218
San Mateo 214
Dublin 208
Ann Arbor 206
Ashburn 203
Nanjing 148
Wilmington 126
New York 125
Boston 99
Nürnberg 98
Marseille 89
Dearborn 79
Houston 70
Woodbridge 69
Milan 66
Princeton 65
Beijing 53
Lawrence 52
Redwood City 51
Cattolica 50
Nanchang 50
Bremen 48
Rome 48
Mountain View 43
Seattle 43
Chicago 42
Brussels 40
University Park 40
Zhengzhou 39
Munich 37
Hangzhou 34
Izmir 34
Delhi 33
Detroit 33
Boardman 32
Fairfield 31
Los Angeles 30
Norwalk 28
Shenyang 28
Lancaster 27
Fremont 26
Helsinki 25
Shanghai 25
Leawood 22
Changsha 21
Hebei 20
Kunming 20
Redmond 19
Tianjin 18
Jiaxing 17
Cambridge 15
Guangzhou 15
Hong Kong 12
Augusta 11
Brescia 11
Jinan 11
Falls Church 10
Hanoi 10
Pune 10
Renton 10
Ningbo 9
Philadelphia 9
Simi Valley 9
Abidjan 8
Indiana 8
Ottawa 8
Toronto 8
Washington 8
Piacenza 7
Canterbury 6
Changchun 6
Kish 6
Lanzhou 6
Singapore 6
Windsor 6
Andover 5
Menlo Park 5
Amsterdam 4
Bergamo 4
Edinburgh 4
Gunzenhausen 4
Hefei 4
Mumbai 4
Palermo 4
West Jordan 4
Zurich 4
Atlanta 3
Auburn 3
Costa Mesa 3
Fuzhou 3
Henderson 3
Isernia 3
Mercato San Severino 3
Monmouth Junction 3
Sacramento 3
San Francisco 3
Southend 3
Taizhou 3
Tappahannock 3
Totale 4.399
Nome #
Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review 224
The treatment of neuroendocrine tumors with long-acting somatostatin analogs: A single center experience with lanreotide autogel 212
Evaluation of antioxidants systems in pituitary-adrenal axis diseases. 193
Double pituitary adenomas 185
Predictors of morbidity and mortality in acromegaly, an Italian survey. 184
Growth hormone in inflammatory bowel disease 176
Seminal antioxidant capacity in pre- and postoperative varicocele 158
Evaluation of Antioxidant systems (Coenzyme Q10 and total antioxidant capacity) in morbidy obesity before and after biliopancreatic diversion 148
Male fertility and reduction in semen parameters: A single tertiary-care center experience 147
Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. 140
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 133
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis 133
Effects of gherlin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 128
Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. 124
Xanthogranuloma of the sellar region: A rare tumor. Case illustration and literature review 123
NOVEL BIOMARKERS OF ANDROGEN DEFICIENCY FROM SEMINAL PLASMA PROFILING USING HIGH-RESOLUTION MASS SPECTROMETRY. 122
Increased estradiol levels in venous occlusive disorder: a possible functional mechanism of venous leakage. 121
An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Single Prospective Monocentric Experience 119
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 115
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study 113
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. 112
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 105
Primary hyperparathyroidism. Our experience 104
Hypothalamitis: a diagnostic and therapeutic challenge 104
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study 103
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography 100
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 99
Isolated growth hormone deficiency: clinical entity? 98
Circulating endothelial cells as marker of endothelial damage in male hypogonadism 98
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 97
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 97
[Immunogenetic and functional study of first-degree relatives of patients with type I diabetes mellitus for identifying prediabetic subjects] 96
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. 95
Radically resected pituitary adenomas: prognostic role of Ki67 labeling index in monocentric retrospective series and literature review 95
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 94
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature 91
Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes 89
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 88
[Coexistence of hyperthyroidism and thyroid carcinoma. Description of a clinical case] 87
Proteomic approach in the identification of fertility pattern in seminal plasma of fertile men 87
Fertility and hypopituitarism 87
Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade 86
Significant GH-deficiency after long-term cure by surgery in adult patients with Cushing s disease 86
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: An immunohistochemical study 86
Naloxone inhibition of postprandial growth hormone releasing hormone-induced growth hormone release in obesity 83
Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. 83
Pancreatic metastases from a bronchopulmonary carcinoid diagnosed by endoscopic ultrasonography-guided fine-needle tissue acquisition 81
Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. 80
GH receptor isoforms and skeletal fragility in acromegaly 80
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second Line Therapies: A Longitudinal Study 79
Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction 78
Increased total antioxidant capacity in seminal plasma of varicocele patients: a multivariate analysis 77
Hormonal and metabolic evaluation in Down's syndrome: preliminary evidence for TSH dysregulation in hyperthyrotropinemic patients 77
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin 75
ACTH-dependent Cushing syndrome: The potential benefits of simultaneous bilateral posterior retroperitoneoscopic adrenalectomy 73
DIAGNOSIS OF ENDOCRINE DISEASE: Primary Empty Sella: a comprehensive review 72
Effects of Testosterone on antioxidant systems in male secondary hypogonadism. 71
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 70
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: clinical effectiveness and predictors of response 69
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 66
Reciprocal regulation of microrna-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions 66
Prevalence of vertebral fractures in men with acromegaly 65
Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. 63
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. 62
The exon 3-deleted growth hormone receptor: Molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions 61
Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle 61
Synchronous Bilateral Adrenalectomy in ACTH-dependent Hypercortisolism: Predictors, Biomarkers and Outcomes 61
Endocrine evaluation of patients with benign lumps of the breast 60
Vertebral fractures in patients with acromegaly: a 3-year prospective study 60
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency 59
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study. 59
Clinical management of teratoma, a rare hypothalamic-pituitary neoplasia 58
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 57
ACROSTUDY: the Italian experience 56
Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure 55
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 55
Plasma prolactin response to gonadotropin-releasing hormone during benzodiazepine treatment 54
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA 53
Human leucocyte antigens coeliac haplotypes and primary autoimmune hypophysitis in caucasian patients 53
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: A multicenter study 51
Endocrine evaluation of patients with benign lumps of the breast 51
Vertebral fractures in males with prolactinoma. 50
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 50
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin 50
Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors. 49
An update of Coenzyme Q10 implications in male infertility: biochemical and therapeutic aspects. 48
The changing clinical spectrum of endocrine adverse events in cancer immunotherapy 48
Empty sella syndrome: Multiple endocrine disorders. 47
The Role of Growth Hormone Receptor Isoforms and Their Effects in Bone Metabolism and Skeletal Fragility 46
Growth hormone receptor isoforms and fracture risk in adult-onset growth hormone-deficient patients. 45
Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours 45
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 44
Effects of high-dose octreotide lar on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy 44
Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism. 44
Understanding the effect of acromegaly on the human skeleton. 44
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion. 41
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. 41
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 41
Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. 41
The management of the patient with acromegaly and headache: a still open clinical challenge. 40
Totale 8.574
Categoria #
all - tutte 30.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.129


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019276 0 0 0 0 0 0 0 0 0 86 92 98
2019/20201.307 235 64 54 52 84 111 248 65 79 74 142 99
2020/2021957 36 103 13 106 117 57 119 22 109 106 157 12
2021/20221.163 60 96 20 79 112 45 26 175 50 66 183 251
2022/20232.397 302 346 194 337 172 283 135 183 266 42 77 60
2023/2024773 61 319 21 43 51 163 37 19 28 31 0 0
Totale 9.223